| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |